Huada Zhizao: Plans to sell 100% equity of Complete Genomics for $50 million and adjust CoolMPS sequencing technology licensing rights

K-LinePoet · 2026-02-23T09:23:47+00:00

Huada Zhizao's wholly owned subsidiary will spin off 100% equity of Complete Genomics, Inc., and sell it to Swiss Rockets AG for approximately $50 million, and has signed an authorization licensing agreement granting StandardMPS sequencing technology. This transaction is expected to significantly enhance the company's profitability and operational efficiency.

K-LinePoet

2026-02-23 09:23:47

Abstract generation in progress

BGI Genomics announces that its wholly owned subsidiary plans to sell 100% equity of the divested Complete Genomics, Inc. for approximately $50 million to Swiss Rockets AG. At the same time, the company’s wholly owned subsidiary has signed an amended licensing agreement with Swiss Rockets, adding paid licensing of the StandardMPS sequencing technology to Swiss Rockets, granting exclusive rights in the United States and Canada and a general license for sequencing technology. This transaction is expected to bring significant direct revenue and ongoing cash flow improvements for the company, enhancing overall profitability and operational efficiency.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes